On-body Injectors Market 2021 Size with Top Countries Industry Chain Structure, Competitive Landscape, Future Trends, New Projects and Forecasts up to 2027 - Medtronic, Insulet, Sensile Medical, Ypsomed, Enable Injections, Roche

The On-body Injectors Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

The Global On-body Injectors Market Size is Projected to Reach at a CAGR of 10% during 2021-2027.

Click Here to Get a Free Sample Copy:

https://www.marketintelligencedata.com/reports/577968/global-on-body-injectors-sales-market-report-2021/inquiry?Mode=rukaiyya

Top Leading Companies:

BD Medical, Medtronic, Insulet, Sensile Medical, Ypsomed, Enable Injections, Roche, ScPharmaceuticals, SteadyMed, CeQur, Tandem Diabetes Care, Valeritas, SteadyMed Therapeutics, Amgen

Recent Development:

Medtronic has acquired 60 companies, including 14 in the last 5 years. A total of 15 acquisitions came from private equity firms. It has also divested 4 assets. Medtronic’s largest acquisition to date was in 2014 when it acquired Covidien for $42.9B. Its largest disclosed sale occurred in 2017 when it sold Medtronic - Patient Care Deep Vein Thrombosis & Nutritional Insufficiency Businesses to Cardinal Health for $6.1B. Medtronic has acquired in 14 different US states, and 8 countries. The Company’s most targeted sectors include medical products (88%) and healthcare services (8%). Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. Medtronic serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.

Roche Holding AG has acquired 42 companies, including 13 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 2 assets. Roche Holding AG’s largest acquisition to date was in 2009 when it acquired Genentech for $46.8B. Roche Holding AG has acquired in 9 different US states, and 9 countries. The Company’s most targeted sectors include life science (67%) and medical products (13%). Roche is a research-focused healthcare company focused on pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche Holding was founded in 1896 and is based in Basel, Switzerland.

On-body Injectors Market Segmentation by Type:

Electronical Injectors
Mechanical Injectors
Others

On-body Injectors Market Segmentation by Application:

Immuno-oncology
Diabetes
Cardiovascular Diseases
Others

Explore Full Report with Detailed TOC Here:

https://www.marketintelligencedata.com/reports/577968/global-on-body-injectors-sales-market-report-2021?Mode=rukaiyya

We will get in touch with you within 24hrs and help you find the research reports and Additional Customization you need.

North America Dominates the Market and Expected to do Same in the Forecast Period

According to the National Cancer Institute (NCI), 1.6 million people were suffering from cancer, and around 0.5 million people died from cancer. This figure indicates that the prevalence of cancer is rapidly increasing in the United States. The most common cancers in the United States are breast cancer, lung cancer, prostate cancer, colon and, bladder cancer, and skin cancer.  Also according to the American Diabetes Association, diabetes has a greater health impact on Americans than heart disease, substance use disorder or COPD, with 30.3 million Americans diagnosed with the illness and many more who are at risk for developing it. The prevalence of these diseases is expected to drive the growth in demand for wearable injectors all across the region.

Regional On-body Injectors Market (Regional Output, Demand & Forecast by Countries)

North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Ecuador, Chile)
Asia Pacific (China, Japan, India, Korea)
Europe (Germany, UK, France, Italy)
Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And additional.

Buy Full Report Here:

https://www.marketintelligencedata.com/report/purchase/577968?mode=su?Mode=rukaiyya

Highlights of the On-body Injectors Market Report:

Detailed overview of On-body Injectors Market
Changing the On-body Injectors market dynamics of the industry
In-depth market segmentation by Type, Application, etc.
Historical, current and projected On-body Injectors market size in terms of volume and value
Recent industry trends and developments
Competitive landscape of On-body Injectors Market
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth.

The research includes historic data from 2016 to 2021 and forecasts until 2027 which makes the report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Finally, the On-body Injectors Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. On-body Injectors industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.

We Offer Customization on Report Based on Specific Client Requirement:

– Free country Level analysis for any 5 countries of your choice.

– Free Competitive analysis of any 5 key market players.

– Free 40 analyst hours to cover any other data point.

ABOUT US:

Market intelligence data is a global front-runner in the research industry, offering customers contextual and data-driven research services. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Intelligence information

Phone: + 1704 266 3234 | 750-707-8687

Email: sales@marketintelligencedata.com

This release was published on openPR.